
Journal of Alloys and Compounds p. 151 - 160 (2001)
Update date:2022-08-04
Topics:
Tefani
Greta
Nomura
Trojko
Musi
The effects of thermal treatment (500, 600, 800 and 1100°C) of the amorphous precursors of ZrO2-Fe2O3 and HfO2-Fe2O3 systems, coprecipitated from aqueous solutions of the corresponding salts, were studied at room temperature (RT) by X-ray powder diffraction (XRD) and, in some cases, by laser Raman spectroscopy. The incorporation of Fe3+ ions partially stabilized the high temperature polymorphs of zirconia (ZrO2) and hafnia (HfO2). The stabilization of the cubic polymorphs of ZrO2 and HfO2 occurred in the solid solutions with an Fe2O3 content of ≥10 mol%. The presence of Fe3+ ions above their solid solubility limit caused the transition of metastable polymorphs of ZrO2 and HfO2 to monoclinic polymorphs. The terminal solid solubility limit of Fe2O3 in ZrO2, as estimated at RT, was ~33 mol% after calcination at 600°C, ~9 mol% after calcination at 800°C and ~2 mol% after calcination at 1100°C. After the same thermal treatment, the terminal solid solubility limits of Fe2O3 in HfO2 proved to be very similar only a little smaller. The unit-cell volume of the cubic polymorphs of ZrO2 and HfO2, determined by powder-pattern-fitting methods, decreased linearly with the increase in iron content, but the rate of decrease was greater in the ZrO2 polymorph. The thermal behavior of the amorphous precursors was also followed by differential thermal analysis and thermogravimetric analysis. The crystallization temperature of both systems increased with an increase in the Fe2O3 content, from 405 to 730°C in the ZrO2-Fe2O3 system, and from 520 to 720°C in the HfO2-Fe2O3 system. The results indicated that the amorphous precursors with more than 30 mol% of Fe2O3 were single co-gels. The status of the Fe3+ ions in the ZrO2-type lattice and the process of their segregation into the α-Fe2O3-phase were examined by57Fe Mo?ssbauer spectroscopy. Significantly lower values of the hyperfine magnetic fields compared to that of α-Fe2O3 indicated the incorporation of Zr4+ ions into the α-Fe2O3 lattice, the amount of which decreased with the increasing temperature of treatment.
Hunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Jinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
Weifang Ocean Trading Co., Ltd.
Contact:+86-536-2081155
Address:Room2606, Yuqing Building, 518#, Yuquan Road, High-tech Development Zone, Weifang City, Shandong Province, China
NINGBO YINLIANG FOREIGN TRADE CO., LTD.
Contact:+86-574-87834016 / 87898057
Address:23F NO.666JINYU ROAD,YINGZHOU DISTRICT,NINGBO.CHINA
Yixing Zhenfen Medical Chemical Co.Ltd
Contact:86-510-87552708
Address:Fenshui ,Yixing city,Jiangsu
Doi:10.1002/aoc.3109
(2014)Doi:10.1021/jo00002a026
(1991)Doi:10.1016/j.saa.2011.09.053
(2012)Doi:10.1039/c1dt10212e
(2011)Doi:10.1039/c4ob01865f
(2015)Doi:10.1002/chem.201804246
(2018)